SRRK Similar Chart Price Prediction
The price of SRRK is predicted to go up 21.94%, based on the high correlation periods with SACH. The similarity of these two price pattern on the periods is 90.26%.
SRRK
SACH
Up: 21.94%Similarity: 90.26%
SRRK Revenue Forecast
SRRK EPS Forecast
SRRK FAQs
What is bull’s view on SRRK?
What is bear's view on SRRK?
SRRK Analyst's Forecast
Allison Bratzel
Piper Sandler
Buy
2024-10-15
Price Target
$28 → $42
Upside
+47.16%
Piper Sandler raised the firm's price target on Scholar Rock to $42 from $28 and keeps an Overweight rating on the shares. The firm continues to recommend Scholar Rock shares and is updating its model following the company's recent financing. Piper continues to believe apitegromab's Phase 3 SAPPHIRE data, along with long-term follow-up data available from the Phase 2 TOPAZ trial, put Scholar Rock in a good spot for regulatory submission in SMA patients ages 2+, and continues to model approval/launch in Q4 2025.
Etzer Darout
BMO Capital
Buy
2024-10-11
Price Target
$34 → $38
Upside
+43.34%
David Nierengarten
Wedbush
Buy
2024-10-07
Price Target
$27 → $37
Upside
+7.93%
